Gene Ontology terms associated with a binding site
- Binding site
- Motif_445
- Name
- PDF2;ATML1
- Description
- Regulation of shoot epidermal cell differentiation by a pair of homeodomain proteins in Arabidopsis. Identification of a cis-regulatory element for L1 layer-specific gene expression, which is targeted by an L1-specific homeodomain protein
- #Associated genes
- 24
- #Associated GO terms
- 331
Biological Process
Molecular Function
Cellular Component
Cellular Component (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0005623 | cell | 11 (45.83%) | 1 | 0 | 0 | 3 | 0 | 5 | 1 | 1 | 0 | 0 |
GO:0044464 | cell part | 11 (45.83%) | 1 | 0 | 0 | 3 | 0 | 5 | 1 | 1 | 0 | 0 |
GO:0005622 | intracellular | 11 (45.83%) | 1 | 0 | 0 | 3 | 0 | 5 | 1 | 1 | 0 | 0 |
GO:0044424 | intracellular part | 11 (45.83%) | 1 | 0 | 0 | 3 | 0 | 5 | 1 | 1 | 0 | 0 |
GO:0043231 | intracellular membrane-bounded organelle | 9 (37.50%) | 1 | 0 | 0 | 2 | 0 | 4 | 1 | 1 | 0 | 0 |
GO:0043229 | intracellular organelle | 9 (37.50%) | 1 | 0 | 0 | 2 | 0 | 4 | 1 | 1 | 0 | 0 |
GO:0043227 | membrane-bounded organelle | 9 (37.50%) | 1 | 0 | 0 | 2 | 0 | 4 | 1 | 1 | 0 | 0 |
GO:0043226 | organelle | 9 (37.50%) | 1 | 0 | 0 | 2 | 0 | 4 | 1 | 1 | 0 | 0 |
GO:0005634 | nucleus | 7 (29.17%) | 1 | 0 | 0 | 2 | 0 | 3 | 0 | 1 | 0 | 0 |
GO:0005737 | cytoplasm | 6 (25.00%) | 0 | 0 | 0 | 2 | 0 | 2 | 1 | 1 | 0 | 0 |
GO:0071944 | cell periphery | 4 (16.67%) | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0005576 | extracellular region | 4 (16.67%) | 1 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0016020 | membrane | 4 (16.67%) | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0005886 | plasma membrane | 4 (16.67%) | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0045177 | apical part of cell | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016324 | apical plasma membrane | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0044444 | cytoplasmic part | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0044446 | intracellular organelle part | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0044425 | membrane part | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0044428 | nuclear part | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0044422 | organelle part | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0044459 | plasma membrane part | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0005773 | vacuole | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0016602 | CCAAT-binding factor complex | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0042995 | cell projection | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044427 | chromosomal part | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0005694 | chromosome | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0000781 | chromosome, telomeric region | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0012505 | endomembrane system | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0031975 | envelope | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0032991 | macromolecular complex | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0043228 | non-membrane-bounded organelle | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0005635 | nuclear envelope | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0031965 | nuclear membrane | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0044798 | nuclear transcription factor complex | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0031967 | organelle envelope | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0031090 | organelle membrane | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0090406 | pollen tube | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043234 | protein complex | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0005667 | transcription factor complex | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Biological Process (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0008152 | metabolic process | 13 (54.17%) | 0 | 0 | 0 | 3 | 0 | 7 | 2 | 1 | 0 | 0 |
GO:0044237 | cellular metabolic process | 10 (41.67%) | 0 | 0 | 0 | 3 | 0 | 6 | 0 | 1 | 0 | 0 |
GO:0009987 | cellular process | 10 (41.67%) | 0 | 0 | 0 | 3 | 0 | 6 | 0 | 1 | 0 | 0 |
GO:0071704 | organic substance metabolic process | 10 (41.67%) | 0 | 0 | 0 | 3 | 0 | 6 | 0 | 1 | 0 | 0 |
GO:0044238 | primary metabolic process | 10 (41.67%) | 0 | 0 | 0 | 3 | 0 | 6 | 0 | 1 | 0 | 0 |
GO:0044699 | single-organism process | 10 (41.67%) | 1 | 0 | 0 | 2 | 0 | 4 | 2 | 1 | 0 | 0 |
GO:0044710 | single-organism metabolic process | 8 (33.33%) | 0 | 0 | 0 | 1 | 0 | 4 | 2 | 1 | 0 | 0 |
GO:0044260 | cellular macromolecule metabolic process | 6 (25.00%) | 0 | 0 | 0 | 2 | 0 | 3 | 0 | 1 | 0 | 0 |
GO:0043170 | macromolecule metabolic process | 6 (25.00%) | 0 | 0 | 0 | 2 | 0 | 3 | 0 | 1 | 0 | 0 |
GO:0044763 | single-organism cellular process | 6 (25.00%) | 0 | 0 | 0 | 2 | 0 | 3 | 0 | 1 | 0 | 0 |
GO:0065007 | biological regulation | 5 (20.83%) | 1 | 0 | 0 | 2 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0009058 | biosynthetic process | 5 (20.83%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 1 | 0 | 0 |
GO:0044249 | cellular biosynthetic process | 5 (20.83%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 1 | 0 | 0 |
GO:1901576 | organic substance biosynthetic process | 5 (20.83%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 1 | 0 | 0 |
GO:0006796 | phosphate-containing compound metabolic process | 5 (20.83%) | 0 | 0 | 0 | 2 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0006793 | phosphorus metabolic process | 5 (20.83%) | 0 | 0 | 0 | 2 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0050789 | regulation of biological process | 5 (20.83%) | 1 | 0 | 0 | 2 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0050896 | response to stimulus | 5 (20.83%) | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0006950 | response to stress | 5 (20.83%) | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0044255 | cellular lipid metabolic process | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0051716 | cellular response to stimulus | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0006629 | lipid metabolic process | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0050794 | regulation of cellular process | 4 (16.67%) | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0009733 | response to auxin | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0042221 | response to chemical | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0009719 | response to endogenous stimulus | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0009723 | response to ethylene | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0009725 | response to hormone | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0009753 | response to jasmonic acid | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0033993 | response to lipid | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0014070 | response to organic cyclic compound | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0010033 | response to organic substance | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:1901700 | response to oxygen-containing compound | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0009751 | response to salicylic acid | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0032774 | RNA biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0016070 | RNA metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0048856 | anatomical structure development | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0019438 | aromatic compound biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0006725 | cellular aromatic compound metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0016043 | cellular component organization | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0071840 | cellular component organization or biogenesis | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0034645 | cellular macromolecule biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0044267 | cellular protein metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0006464 | cellular protein modification process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0006952 | defense response | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0048589 | developmental growth | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0032502 | developmental process | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010467 | gene expression | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0040007 | growth | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0018130 | heterocycle biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0046483 | heterocycle metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0009059 | macromolecule biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0043412 | macromolecule modification | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0007275 | multicellular organismal development | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0032501 | multicellular organismal process | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0006807 | nitrogen compound metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0090304 | nucleic acid metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0048513 | organ development | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:1901362 | organic cyclic compound biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:1901360 | organic cyclic compound metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0055114 | oxidation-reduction process | 3 (12.50%) | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 |
GO:0019538 | protein metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0036211 | protein modification process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:2001141 | regulation of RNA biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0051252 | regulation of RNA metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0009889 | regulation of biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0031326 | regulation of cellular biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0031323 | regulation of cellular metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0010468 | regulation of gene expression | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0010556 | regulation of macromolecule biosynthetic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0060255 | regulation of macromolecule metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0019222 | regulation of metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0080090 | regulation of primary metabolic process | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0006355 | regulation of transcription, DNA-dependent | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0009739 | response to gibberellin stimulus | 3 (12.50%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0044707 | single-multicellular organism process | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0044767 | single-organism developmental process | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048731 | system development | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009888 | tissue development | 3 (12.50%) | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0006351 | transcription, DNA-templated | 3 (12.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
GO:0009653 | anatomical structure morphogenesis | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0046394 | carboxylic acid biosynthetic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0019752 | carboxylic acid metabolic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0007154 | cell communication | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0008219 | cell death | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0048468 | cell development | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0030154 | cell differentiation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016049 | cell growth | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048469 | cell maturation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0000902 | cell morphogenesis | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0000904 | cell morphogenesis involved in differentiation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009932 | cell tip growth | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0032989 | cellular component morphogenesis | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048869 | cellular developmental process | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0033554 | cellular response to stress | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0016265 | death | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0048588 | developmental cell growth | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0060560 | developmental growth involved in morphogenesis | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0021700 | developmental maturation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009913 | epidermal cell differentiation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0008544 | epidermis development | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0030855 | epithelial cell differentiation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0060429 | epithelium development | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0006633 | fatty acid biosynthetic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0006631 | fatty acid metabolic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0046486 | glycerolipid metabolic process | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0006650 | glycerophospholipid metabolic process | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0034050 | host programmed cell death induced by symbiont | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0006955 | immune response | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0002376 | immune system process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0045087 | innate immune response | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0008610 | lipid biosynthetic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0072330 | monocarboxylic acid biosynthetic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0032787 | monocarboxylic acid metabolic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0051704 | multi-organism process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0016053 | organic acid biosynthetic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0006082 | organic acid metabolic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0019637 | organophosphate metabolic process | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0043436 | oxoacid metabolic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0046488 | phosphatidylinositol metabolic process | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0006644 | phospholipid metabolic process | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016310 | phosphorylation | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0009626 | plant-type hypersensitive response | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0012501 | programmed cell death | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0006468 | protein phosphorylation | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0009628 | response to abiotic stimulus | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0009737 | response to abscisic acid | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0097305 | response to alcohol | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0009617 | response to bacterium | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0009607 | response to biotic stimulus | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0046686 | response to cadmium ion | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0010035 | response to inorganic substance | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0010038 | response to metal ion | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0006970 | response to osmotic stress | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0051707 | response to other organism | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0009651 | response to salt stress | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0048364 | root development | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010053 | root epidermal cell differentiation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0080147 | root hair cell development | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048765 | root hair cell differentiation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048768 | root hair cell tip growth | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048767 | root hair elongation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010015 | root morphogenesis | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0022622 | root system development | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0007165 | signal transduction | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0023052 | signaling | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0044700 | single organism signaling | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0044711 | single-organism biosynthetic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0043588 | skin development | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0044283 | small molecule biosynthetic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0044281 | small molecule metabolic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0010054 | trichoblast differentiation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048764 | trichoblast maturation | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009826 | unidimensional cell growth | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0000038 | very long-chain fatty acid metabolic process | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0006259 | DNA metabolic process | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0000279 | M phase | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0051322 | anaphase | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0060249 | anatomical structure homeostasis | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0007049 | cell cycle | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0022403 | cell cycle phase | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0022402 | cell cycle process | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0048610 | cellular process involved in reproduction | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0070887 | cellular response to chemical stimulus | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0071495 | cellular response to endogenous stimulus | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0071369 | cellular response to ethylene stimulus | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0032870 | cellular response to hormone stimulus | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0071310 | cellular response to organic substance | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0051276 | chromosome organization | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0072583 | clathrin-mediated endocytosis | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016311 | dephosphorylation | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006897 | endocytosis | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051234 | establishment of localization | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009873 | ethylene mediated signaling pathway | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0042592 | homeostatic process | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0009755 | hormone-mediated signaling pathway | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0035556 | intracellular signal transduction | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051179 | localization | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007133 | meiotic anaphase I | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0048507 | meristem development | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0035266 | meristem growth | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010073 | meristem maintenance | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048519 | negative regulation of biological process | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0031348 | negative regulation of defense response | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048585 | negative regulation of response to stimulus | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006996 | organelle organization | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0000160 | phosphorelay signal transduction system | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0006470 | protein dephosphorylation | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006898 | receptor-mediated endocytosis | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051052 | regulation of DNA metabolic process | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0065008 | regulation of biological quality | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0051128 | regulation of cellular component organization | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0033044 | regulation of chromosome organization | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0031347 | regulation of defense response | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048638 | regulation of developmental growth | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0050793 | regulation of developmental process | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0040008 | regulation of growth | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0032844 | regulation of homeostatic process | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0048509 | regulation of meristem development | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010075 | regulation of meristem growth | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:2000026 | regulation of multicellular organismal development | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051239 | regulation of multicellular organismal process | 1 (4.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0033043 | regulation of organelle organization | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0048583 | regulation of response to stimulus | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0080134 | regulation of response to stress | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0032204 | regulation of telomere maintenance | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0000003 | reproduction | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0080167 | response to karrikin | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009415 | response to water | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009414 | response to water deprivation | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0000723 | telomere maintenance | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0032200 | telomere organization | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0006810 | transport | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016192 | vesicle-mediated transport | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Molecular Function (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0005488 | binding | 14 (58.33%) | 0 | 1 | 0 | 2 | 0 | 7 | 3 | 1 | 0 | 0 |
GO:0003824 | catalytic activity | 8 (33.33%) | 0 | 0 | 0 | 2 | 0 | 4 | 2 | 0 | 0 | 0 |
GO:1901363 | heterocyclic compound binding | 8 (33.33%) | 0 | 0 | 0 | 1 | 0 | 6 | 0 | 1 | 0 | 0 |
GO:0097159 | organic cyclic compound binding | 8 (33.33%) | 0 | 0 | 0 | 1 | 0 | 6 | 0 | 1 | 0 | 0 |
GO:0005515 | protein binding | 8 (33.33%) | 0 | 1 | 0 | 1 | 0 | 4 | 1 | 1 | 0 | 0 |
GO:0043167 | ion binding | 6 (25.00%) | 0 | 1 | 0 | 0 | 0 | 3 | 2 | 0 | 0 | 0 |
GO:0016740 | transferase activity | 6 (25.00%) | 0 | 0 | 0 | 1 | 0 | 3 | 2 | 0 | 0 | 0 |
GO:0003677 | DNA binding | 5 (20.83%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 1 | 0 | 0 |
GO:0003676 | nucleic acid binding | 5 (20.83%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 1 | 0 | 0 |
GO:0003682 | chromatin binding | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
GO:0016301 | kinase activity | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 4 (16.67%) | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0043168 | anion binding | 3 (12.50%) | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0043169 | cation binding | 3 (12.50%) | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0046872 | metal ion binding | 3 (12.50%) | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:1901265 | nucleoside phosphate binding | 3 (12.50%) | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0000166 | nucleotide binding | 3 (12.50%) | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0016491 | oxidoreductase activity | 3 (12.50%) | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 |
GO:0036094 | small molecule binding | 3 (12.50%) | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
GO:0046914 | transition metal ion binding | 3 (12.50%) | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0008270 | zinc ion binding | 3 (12.50%) | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0005524 | ATP binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0030554 | adenyl nucleotide binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0032559 | adenyl ribonucleotide binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0097367 | carbohydrate derivative binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0031072 | heat shock protein binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0001882 | nucleoside binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0016307 | phosphatidylinositol phosphate kinase activity | 2 (8.33%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0004672 | protein kinase activity | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0004674 | protein serine/threonine kinase activity | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0001883 | purine nucleoside binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0017076 | purine nucleotide binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0032550 | purine ribonucleoside binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0032555 | purine ribonucleotide binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0032549 | ribonucleoside binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0032553 | ribonucleotide binding | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:0016746 | transferase activity, transferring acyl groups | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0016747 | transferase activity, transferring acyl groups other than amino-acyl groups | 2 (8.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0008301 | DNA binding, bending | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0033549 | MAP kinase phosphatase activity | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0033550 | MAP kinase tyrosine phosphatase activity | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0004499 | N,N-dimethylaniline monooxygenase activity | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0050661 | NADP binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0050662 | coenzyme binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048037 | cofactor binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0003690 | double-stranded DNA binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0003691 | double-stranded telomeric DNA binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0050660 | flavin adenine dinucleotide binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016787 | hydrolase activity | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016788 | hydrolase activity, acting on ester bonds | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042802 | identical protein binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0004497 | monooxygenase activity | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0001071 | nucleic acid binding transcription factor activity | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016791 | phosphatase activity | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0004721 | phosphoprotein phosphatase activity | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042578 | phosphoric ester hydrolase activity | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046983 | protein dimerization activity | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0042803 | protein homodimerization activity | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0004725 | protein tyrosine phosphatase activity | 1 (4.17%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043565 | sequence-specific DNA binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0043566 | structure-specific DNA binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0042162 | telomeric DNA binding | 1 (4.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |